Literature DB >> 21596024

Effects of highly active novel artemisinin-chloroquinoline hybrid compounds on β-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum.

Tzu-Shean Feng1, Eric M Guantai, Margo Nell, Constance E J van Rensburg, Kanyile Ncokazi, Timothy J Egan, Heinrich C Hoppe, Kelly Chibale.   

Abstract

4-Aminoquinolines were hybridized with artemisinin and 1,4-naphthoquinone derivatives via the Ugi-four-component condensation reaction, and their biological activities investigated. The artemisinin-containing compounds 6a-c and its salt 6c-citrate were the most active target compounds in the antiplasmodial assays. However, despite the potent in vitro activities, they also displayed cytotoxicity against a mammalian cell-line, and had lower therapeutic indices than chloroquine. Morphological changes in parasites treated with these artemisinin-containing hybrid compounds were similar to those observed after addition of artemisinin. These hybrid compounds appeared to share mechanism(s) of action with both chloroquine and artemisinin: they exhibited potent β-hematin inhibitory activities; they caused an increase in accumulation of hemoglobin within the parasites that was intermediate between the increase observed with artesunate and chloroquine; and they also appeared to inhibit endocytosis as suggested by the decrease in the number of transport vesicles in the parasites. No cross-resistance with chloroquine was observed for these hybrid compounds, despite the fact that they contained the chloroquinoline moiety. The hybridization strategy therefore appeared to be borrowing the best from both classes of antimalarials.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596024     DOI: 10.1016/j.bcp.2011.04.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Drug delivery to the malaria parasite using an arterolane-like scaffold.

Authors:  Shaun D Fontaine; Benjamin Spangler; Jiri Gut; Erica M W Lauterwasser; Philip J Rosenthal; Adam R Renslo
Journal:  ChemMedChem       Date:  2014-10-14       Impact factor: 3.466

Review 2.  Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?

Authors:  Drishti Agarwal; Rinkoo D Gupta; Satish K Awasthi
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite.

Authors:  Sumit S Mahajan; Jiri Gut; Philip J Rosenthal; Adam R Renslo
Journal:  Future Med Chem       Date:  2012-12       Impact factor: 3.808

Review 4.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  The molecular and cellular action properties of artemisinins: what has yeast told us?

Authors:  Chen Sun; Bing Zhou
Journal:  Microb Cell       Date:  2016-04-14

6.  Artemisinin-(Iso)quinoline Hybrids by C-H Activation and Click Chemistry: Combating Multidrug-Resistant Malaria.

Authors:  Aysun Çapcı; Mélanie M Lorion; Hui Wang; Nina Simon; Maria Leidenberger; Mariana C Borges Silva; Diogo R M Moreira; Yongping Zhu; Yuqing Meng; Jia Yun Chen; Yew Mun Lee; Oliver Friedrich; Barbara Kappes; Jigang Wang; Lutz Ackermann; Svetlana B Tsogoeva
Journal:  Angew Chem Int Ed Engl       Date:  2019-08-08       Impact factor: 15.336

7.  Artemisinin resistance in rodent malaria--mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking.

Authors:  Gisela Henriques; Axel Martinelli; Louise Rodrigues; Katarzyna Modrzynska; Richard Fawcett; Douglas R Houston; Sofia T Borges; Umberto d'Alessandro; Halidou Tinto; Corine Karema; Paul Hunt; Pedro Cravo
Journal:  Malar J       Date:  2013-04-05       Impact factor: 2.979

Review 8.  Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.

Authors:  Sijongesonke Peter; Siphesihle Jama; Sibusiso Alven; Blessing A Aderibigbe
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.